- This event has passed.
The Art of Collaboration: A Successful Project Consortium
December 3, 2020 @ 11:00 am - 12:30 pmFree
Collaboration is built in the foundation of the Digital Technology Supercluster and is critical to project success. With the ongoing call for projects in our Technology Leadership Program, we are committed to providing you with the tools and knowledge to engage, develop strong project ideas and proposals and build a successful consortium.
The Art of Collaboration will look at best practices and lessons learned from building and managing a successful consortium. Topics include how to build trust and define roles, what happens when things don’t go as planned, and factors to consider when defining your project “north star”.
Why you should attend:
- Develop a better understanding of how the Supercluster model works, program objectives and considerations when developing successful proposals
- Learn first-hand from Members who have gone through the process and will share best practices and lessons learned from their experiences
- Connect with other Members and Associates of the Supercluster
Speaker and Moderator: Jenn Mielguj, Program Associate at Digital Technology Supercluster
- Balraj Bains, Director, Corporate Development at Providence Health Care
Bal is the Director of Corporate Development at Providence Health Care (PHC) where she plays a key role in identifying new revenue sources, developing business models and platforms and providing commercial advisory services for start-up concepts and a pathway for returns.
A strategic and big picture thinker, Bal’s experience spans start-ups, non-profits to large biotech companies. Bal’s passion for enabling innovation is a perfect fit for Supercluster initiatives and she leads the development and management of PHC innovation initiatives with the Canadian Digital Technology Supercluster.
PHC is a key partner in 5 Supercluster projects. They include: Dermatology Point of Care Intelligent Network (DermInt), Intelligent Network for Point-of-Care Ultrasound (IN PoCUS and IN-PoCUS for COVID), Perioperative Opioid Usage Quality Improvement (POQI), HyperTalent Capacity Building and Authorization, Booking, and Coordination of Widespread Serological Testing and Immunization (Project ABC).
Bal holds a MBA in executive management from Royal Roads and double diplomas in business administration and biotechnology from BC Institute of Technology. Her interests include CrossFit, kickboxing, hot yoga, traveling, hiking, reading and connecting with like-minded individuals.
- Robert Bennett, COO & Program Director at VIATEC
Rob has been involved in multiple local tech companies as a software developer, founder, investor, mentor and coach. He’s also participated in various community organizations and boards, always with a keen eye to community and economic development. Though Rob started in the technical track, he quickly learned how it’s people that make the difference.
Rob has been working with VIATEC in different roles for over 15 years, alongside a team of passionate people supporting innovation and entrepreneurship in tech companies. His current role is Chief Operating Officer and Program Director, assisting entrepreneurs with the development of their start-up and early stage companies through a variety events, programs and resources, most notably through the W Venture and the VIATEC Accelerator programs.
- Robert Fraser, CEO at Molecular You
Dr. Robert Fraser is the President and CEO of Molecular You, a digital health company utilizing integrated biomarker analyses to deliver personalized health insights and action plans. As a co-founder of The Personalized Medicine Initiative (PMI), Dr. Fraser has been at the forefront of developing the framework and technologies to bring personalized medicine into healthcare practice. Backed by his expertise in molecular diagnostics, molecularly-targeted drug discovery and development, biochemistry and regulatory compliance, Dr. Fraser has been a leader in the implementation of personalized care in Canada. He has also been involved in leading drug discovery and development projects at Sanofi, Xenon, Neuromed and CDRD. Dr. Fraser received extensive training in the molecular mechanisms of endocrinology while completing his Ph.D. at the University of Alberta and Harvard Medical School and Post-Doctoral Fellowships at Hospital for Sick Children, Toronto and IGBMC, Strasbourg France. In addition to Dr. Fraser’s scientific accomplishments, he has been involved in the raising of more than $37M in funding. Dr. Fraser is also co-founder of GenXys Health Care Systems, Personalized Biomarkers Incorporated, Mesentech and Novobind Inc.
- Robert Attwell, COO and Founder at Careteam Technologies
Rob Attwell is an entrepreneur who has extensive experience helping large healthcare organizations with major innovation and transformation initiatives. He is responsible for strategic initiatives and partnerships including Careteam’s work with the Canadian Digital Technology Supercluster. Rob is Advisor to and Past Chair of the Neil Squire Society, a national not-for-profit providing services to Canadians with disabilities. He has an MBA from the Richard Ivey School of Business where he was recognized as an Ivey Scholar and is recipient of the Ivey Alumni Award.
11:00 a.m. PT Introduction + Presentation
11:20 a.m. PT Member Panel
12:00p.m. PT Q&A
If you have any questions in advance of our webinar, please send them to email@example.com and we will be sure to address your questions during our webinar.